| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,490 | 2,770 | 31.10. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CAREIUM Aktie jetzt für 0€ handeln | |||||
| 22.10. | Careium AB Profit Advances In Q3 | 1 | RTTNews | ||
| 22.10. | Careium AB: Careium reports thirds quarter results 2026 | 168 | GlobeNewswire (Europe) | The third quarter in summaryNet sales increased by 21.6 percent to SEK 259.9 million (213.7)Growth adjusted for currency effects was 19.9 percentContinued strong growth in all marketsGross margin increased... ► Artikel lesen | |
| 10.07. | Careium AB Announces Advance In Q2 Bottom Line | 1 | RTTNews | ||
| 10.07. | Careium steigert Umsatz im Q2 um 24 % dank Neukunden im Vereinigten Königreich und Norwegen | 1 | Investing.com Deutsch | ||
| 10.07. | Careium AB: Careium reports second quarter results 2026 | 447 | GlobeNewswire (Europe) | The second quarter in summaryNet sales increased by 24.3 percent to SEK 251.3 million (202.1)Organic growth 25.6 percent adjusted for currency effectsGrowth in all marketsGross margin amounted to 42.5... ► Artikel lesen | |
| 09.07. | Careium AB: Careium repays hybrid loan to simplify capital structure | 260 | GlobeNewswire (Europe) | In connection with the listing of Careium AB (publ) ("Careium" or the "company") on Nasdaq First North Growth Market in 2021, the company raised a hybrid loan of SEK 50 million from its former owner... ► Artikel lesen | |
| 23.04. | Careium AB: Report from Annual General Meeting in Careium AB (publ) | 264 | GlobeNewswire (Europe) | At the Annual General Meeting in Careium AB (publ) ("Careium" or the "company") held on 23 April 2026, the following resolutions were passed. All resolutions were in accordance with the proposals, described... ► Artikel lesen | |
| 23.04. | Careium AB: Careium reports first quarter results 2026 | 429 | GlobeNewswire (Europe) | Summary first quarter 2026
Net sales increased by 5.9 percent to SEK 219.6 million (207.4)Net sales increased by 10.9 percent adjusted for currency effectsGrowth in all markets, adjusted for currency... ► Artikel lesen | |
| 27.03. | Careium AB: Tove Christiansson joins as CEO of Careium on June 1 | 275 | GlobeNewswire (Europe) | As earlier communicated, Tove Christiansson has been appointed CEO of Careium. Her first day in office will be June 1.
Tove holds a bachelor's degree from Lund University and brings over 20 years of... ► Artikel lesen | |
| 11.02. | Careium AB: Careium reports fourth quarter results 2025 | 440 | GlobeNewswire (Europe) | Summary fourth quarter 2025Net sales increased by 0.9 percent to SEK 230.9 million (228.9)Net sales increased by 6.3 percent adjusted for currency effectsNet sales increased by 13.1 percent adjusted... ► Artikel lesen | |
| 11.12.25 | Careium AB: Careium comments on full-year results | 336 | GlobeNewswire (Europe) | Careium's operations are developing well, however we are currently experiencing longer sales cycles than expected in UK and Germany for product sales. This impacts net sales, profitability and cashflow.... ► Artikel lesen | |
| 02.12.25 | Careium AB: Tove Christiansson appointed CEO of Careium | 366 | GlobeNewswire (Europe) | The Board of Directors of Careium has appointed Tove Christiansson as the CEO, effective Q2 2026. She succeeds interim CEO Peter Heuman, who will remain in his current role until the transition has... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 47,795 | +1,69 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Fresenius mit einem Kursziel von 55,20 Euro auf "Overweight" belassen. Für die Quartalszahlen des Medizinkonzerns am 4. November liege er beim... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 42,890 | 0,00 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| THERMO FISHER | 621,80 | -0,32 % | Thermo Fisher Scientific: Executive Vice President Michael D. Shafer kündigt Ruhestand für Ende 2026 an | ||
| EUROFINS SCIENTIFIC | 87,22 | -0,27 % | Eurofins Scientific SE: Eurofins Scientific: Director/PDMR Shareholding | Eurofins Scientific SE (Paris:ERF) (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each... ► Artikel lesen | |
| SYNLAB | - | - | EQS-News: SYNLAB: Synnovis and Apian partner to advance drone and autonomous robotics in healthcare logistics | EQS-News: SYNLAB
/ Key word(s): Miscellaneous
Synnovis and Apian partner to advance drone and autonomous robotics in healthcare logistics
07.09.2026 / 09:31 CET/CEST
The... ► Artikel lesen | |
| DAVITA | 172,55 | +3,29 % | DaVita Inc. Profit Advances In Q3 | WASHINGTON (dpa-AFX) - DaVita Inc. (DVA) announced earnings for its third quarter that Increases, from last yearThe company's earnings totaled $222.931 million, or $3.40 per share. This compares... ► Artikel lesen | |
| DENTSPLY SIRONA | 8,530 | -0,07 % | DENTSPLY SIRONA Inc.: Wellspect HealthCare Announces U.S. Medicare Reimbursement Access for Surity Urinary Management Portfolio | Traditional Medicare reimbursement supports broader access to non-invasive management options for eligible beneficiaries living with permanent urinary incontinence MÖLNDAL, Sweden, Oct. 07, 2026... ► Artikel lesen | |
| SMITH & NEPHEW | 13,400 | -1,47 % | PRESSESPIEGEL/Unternehmen: MERCEDES, DEUTSCHE BAHN, AUDI, SONNEN, JOHNSON & JOHNSON/SMITH & NEPHEW | DJ PRESSESPIEGEL/Unternehmen
Die wirtschaftsrelevanten Themen aus den Medien, zusammengestellt von Dow Jones Newswires.
MERCEDES - Der Autokonzern Mercedes-Benz will die nächste Fahrzeug-Generation... ► Artikel lesen | |
| SONIC HEALTHCARE | 12,242 | +0,74 % | SONIC HEALTHCARE LIMITED: Notice of change of interests of substantial holder for MAP | ||
| DIASORIN | 80,02 | -0,52 % | DiaSorin Reports Lower H1 Profit, Confirms FY26 Outlook | ROME (dpa-AFX) - DiaSorin S.p.A. (DIA.MI) on Friday, reported lower revenue and net profit for the first half of 2026, as higher operating expenses and weaker profitability offset growth recorded... ► Artikel lesen | |
| FULGENT GENETICS | 18,400 | 0,00 % | Fulgent expects $330M-$340M 2026 revenue as billing transition lowers collection rates | ||
| PERSPECTIVE THERAPEUTICS | 1,000 | -2,20 % | BMO bekräftigt Einstufung für Perspective Therapeutics - Zuversicht dank starker Technologieplattform | ||
| IMPLANTICA | 5,910 | -4,83 % | Implantica AG: Implantica announces leading U.S. surgeon participates in RefluxStop training surgeries | Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, today announced that Dr. John C. Lipham, Professor of Surgery at the University of Southern... ► Artikel lesen | |
| OMNICELL | 32,600 | -0,61 % | Omnicell anticipates $1.225B-$1.231B 2026 revenue while raising non-GAAP EBITDA to $187M-$193M | ||
| SPINEGUARD | 0,066 | +5,62 % | SpineGuard Announces Its Q3 Revenue | A +22% increase in the total number of units sold during the period Sales growing +25% outside the United States A return to volume growth in the United States and confirmation of... ► Artikel lesen |